Quick Answer
Entera Bio Ltd. reported Total Assets of $15.99 million for fiscal year 2025.
Entera Bio Ltd. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $15.99M | +70.3% |
| 2024 | $9.39M | -20.2% |
| 2023 | $11.77M | -10.4% |
| 2022 | $13.13M | -49.5% |
| 2021 | $25.99M | +167.3% |
| 2020 | $9.72M | -41.8% |
| 2019 | $16.70M | +25.2% |
| 2018 | $13.34M | +0.5% |
| 2017 | $13.28M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $17.41M | +124.9% | -11.5% |
| June 30, 2025 | $19.67M | +96.0% | -8.9% |
| March 31, 2025 | $21.60M | +111.0% | +130.0% |
| December 31, 2024 | $9.39M | -20.2% | +21.3% |
| September 30, 2024 | $7.74M | -9.6% | -22.9% |
| June 30, 2024 | $10.04M | -3.9% | -2.0% |
| March 31, 2024 | $10.24M | -11.8% | -13.0% |
| December 31, 2023 | $11.77M | -10.4% | +37.4% |
- Entera Bio Ltd. showed an increase of +70.3% in Total Assets compared to the prior fiscal year.
- Over the 2017–2025 period, Entera Bio Ltd.’s total assets has grown by 20.4% (from $13.28 million to $15.99 million).
- The most recent figure is from Entera Bio Ltd.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: